Stereotaxis Completes $20 Mln Acquisition Of Robocath

July 09, 2026 — 11:36 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Stereotaxis Inc. (STXS), a surgical robotics company, on Thursday announced the acquisition of Robocath, an established robotics company for interventions in cardiology and neurointerventions.

The companies plan to pool resources in developing next-generation robotic solutions for electrophysiology, interventional cardiology, and endovascular procedures.

Stereotaxis previously announced the acquisition in April 2026 via a share sale agreement worth approximately $20 million in cash and common stock.

With the agreement, the company also gains Robocath's proprietary R-One technology, which has shown a 98% technical procedure success with no major cardiovascular events reported. The technique has received clearance in Europe and China.

STXS is currently trading at $1.76, down 2.22%

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Stereotaxis Completes $20 Mln Acquisition Of Robocath

Tags

Latest Articles